Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Net Cash Flow (2024 - 2025)

Connect Biopharma Holdings' Net Cash Flow history spans 2 years, with the latest figure at -$2.8 million for Q3 2025.

  • For Q3 2025, Net Cash Flow rose 78.37% year-over-year to -$2.8 million; the TTM value through Sep 2025 reached -$56.4 million, down 536.66%, while the annual FY2024 figure was -$3.2 million, 104.3% down from the prior year.
  • Net Cash Flow for Q3 2025 was -$2.8 million at Connect Biopharma Holdings, up from -$7.3 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $8.7 million in Q1 2024 and bottomed at -$30.6 million in Q1 2025.